Related Experiment Video
Updated: Jun 8, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Cytochrome P450 2B1 mediates complement-dependent sublytic injury in a model of membranous nephropathy
Hua Liu1, Niu Tian, Istvan Arany
1Department of Pediatrics, 5 P42 ES07381 , USA.
Abstract:
Membranous nephropathy is a disease that affects the filtering units of the kidney, the glomeruli, and results in proteinuria accompanied by loss of kidney function. Passive Heymann nephritis is an experimental model that mimics membranous nephropathy in humans, wherein the glomerular epithelial cell (GEC) injury induced by complement C5b-9 leads to proteinuria. We examined the role of cytochrome P450 2B1 (CYP2B1) in this complement-mediated sublytic injury. Overexpression of CYP2B1 in GECs significantly increased the formation of reactive oxygen species, cytotoxicity, and collapse of the actin cytoskeleton following treatment with anti-tubular brush-border antiserum (anti-Fx1A). In contrast, silencing of CYP2B1 markedly attenuated anti-Fx1A-induced reactive oxygen species generation and cytotoxicity with preservation of the actin cytoskeleton. Gelsolin, which maintains an organized actin cytoskeleton, was significantly decreased by complement C5b-9-mediated injury but was preserved in CYP2B1-silenced cells. In rats injected with anti-Fx1A, the cytochrome P450 inhibitor cimetidine blocked an increase in catalytic iron and ROS generation, reduced the formation of malondialdehyde adducts, maintained a normal distribution of nephrin in the glomeruli, and provided significant protection at the onset of proteinuria. Thus, GEC CYP2B1 contributes to complement C5b-9-mediated injury and plays an important role in the pathogenesis of passive Heymann nephritis.
Insights
Cytochrome P450 2B1 (CYP2B1) exacerbates kidney damage in membranous nephropathy models. Inhibiting CYP2B1 protects against injury and proteinuria, highlighting its role in disease development.
Area of Science:
- Nephrology
- Molecular Biology
- Biochemistry
Background:
- Membranous nephropathy causes proteinuria and kidney dysfunction.
- Passive Heymann nephritis models human disease, involving glomerular epithelial cell (GEC) injury via complement C5b-9.
- The role of cytochrome P450 2B1 (CYP2B1) in this injury is unclear.
Purpose of the Study:
- To investigate the role of CYP2B1 in complement-mediated GEC injury in passive Heymann nephritis.
- To determine if CYP2B1 contributes to the pathogenesis of this kidney disease model.
Main Methods:
- Overexpression and silencing of CYP2B1 in GECs.
- Assessment of reactive oxygen species (ROS) generation, cytotoxicity, and actin cytoskeleton integrity.
- In vivo studies in rats using the anti-Fx1A model and treatment with a CYP450 inhibitor (cimetidine).
Main Results:
- CYP2B1 overexpression increased ROS, cytotoxicity, and actin collapse in GECs.
- CYP2B1 silencing reduced ROS, cytotoxicity, and preserved the actin cytoskeleton and gelsolin.
- In vivo, cimetidine inhibited ROS, reduced oxidative damage, maintained nephrin distribution, and prevented proteinuria.
Conclusions:
- GEC CYP2B1 significantly contributes to complement C5b-9-mediated injury.
- CYP2B1 plays a critical role in the pathogenesis of passive Heymann nephritis.
- Targeting CYP2B1 may offer a therapeutic strategy for membranous nephropathy.
Related Concept Videos
Complement System
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Hypersensitivity Reactions: Cytolytic Reactions
Acute Kidney Injury II: Pathophysiology
Bioactivation and Tissue Toxicity
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...

